Similarly, in a study of 75 SLE patients, Liu et al. found plasma VEGF levels to be significantly higher in subjects with active SLE (SLEDAI > 4) compared to healthy controls and patients with inactive SLE (SLEDAI ≤ 4). This evidence concerns the gene VEGFA and systemic lupus erythematosus.